New film: what does the mushroom name "Amazonian" actually tell you?
We checked it against museum specimens, old ads, genome data and lab tests. Earliest dated use we found: a Dec 1977 ad. Origin: not given.
https://t.co/uN4LE1DvrP
The FDA's Sep 14 psychedelics hearing was not about legalization or scheduling. Its four topics, for supervised use: provider training and credentialing, patient safety, access, and data collection. Comments close Monday, Oct 5, 11:59 pm ET. The notice: https://t.co/Wjr2F2cgui
@syzygetics Massospora fits, but the drugs come from separate pairings: Boyce et al. 2019 found cathinone in infected periodical cicadas and psilocybin in annual cicadas with another Massospora. Some infected periodical males flick their wings like receptive females, luring other males in.
@CBSNews FDA approval hasn't come yet for any psilocybin drug, and Compass Pathways expects to finish filing by year-end. RAND's 2025 survey found 54% of veterans backed VA coverage of psilocybin therapy if approved, while nearly 1 in 4 backed legal mushroom use.
@CarverJohns In the Johns Hopkins pilot (just 4 volunteers), two mistook synthetic THC for a classic psychedelic. The bigger payoff may be in trials: psilocybin is so recognizable that blinding has largely failed, and the same team has floated high-THC cannabis as an active comparator.
@ManDearSir In Cormac's Glossary, imbas forosnai starts with a poet chewing the flesh of a red pig, dog or cat. He chants over it, offers it to idol-gods, then sleeps with palms on cheeks, watched until all is revealed. No mushroom appears, and the glossary says Patrick abolished the rite.
@aroundliv Liberty caps are decomposers living off decaying grass roots, so they sit outside the tree partnerships behind the Wood Wide Web. And the tree-sharing story is shakier than it sounds. A 2023 review found field results on networks feeding seedlings too varied to generalize from.
@LoriShemek The 45% comes from a Penn State meta-analysis of 17 observational studies, mostly case-control, so it's an association, not proof. The lead author points to ergothioneine: some fungi and bacteria make it, humans can't, and we evolved a highly selective transporter for it.
@NextScience That 'temporarily inaccessible' idea is central to paradoxical lucidity research. With no psychedelic involved, a 2025 study filming 20 people with advanced dementia validated 9 lucid episodes in 3 of them. The case authors note spontaneous change can't be excluded.
The name sounds like a joke.
But how much of the story should you actually believe? 🍄
Penis Envy.
You’ve heard the name. You may have heard the potency claims, the origin stories, and the legends surrounding it.
But a story repeated a thousand times doesn’t automatically become scientific fact.
Where did its reputation come from? What do we actually know about the mushroom behind the name? And where does evidence end and folklore begin?
Forget the hype for a moment. Let’s get curious.
🎬 Penis Envy: The Mushroom Behind the Myth
Enter the Shroomverse for a cinematic exploration of the questions behind the legend.
Watch the full documentary 👇
https://t.co/uA3p6l7Pcx
What’s the biggest claim you’ve heard about Penis Envy—and did you believe it?
#Shroomverse #Mycology
In 2021, one bag of mushrooms tested at 3.82%, more than four times the average at Oakland's Psilocybin Cup. The label said Tidal Wave.
But it was one sample, not a strain. Here's why that matters 👇
#Psilocybin#Mycology#MushroomScience https://t.co/irXKInEYE8
DMT is fascinating because the experience can shift dramatically long before a full “breakthrough.” 🧠✨
People report intense geometric imagery, altered depth and color, and powerful euphoria even at lower intensities.
But subjective effects vary a lot person to person — which is exactly why DMT remains such an interesting target for consciousness research.
🍄 Mushroom potency can vary dramatically — even within the same species.
Genetics matter.
Growing conditions matter.
Harvest timing matters.
And the name printed on a strain doesn’t always tell you exactly what you’re getting.
So what happens when researchers actually test them?
We broke down one of the most extreme potency results on record 👇
🎥 https://t.co/9EknvPH8xH
Golden Teacher is one of the best-known varieties of Psilocybe cubensis — but the clinical research isn’t about “Golden Teachers” specifically. 🍄🧠
Researchers are studying psilocybin itself for conditions including depression, where serotonin signaling, neuroplasticity and psychological experience may all play a role.
The mushroom gets the attention.
The molecule is where the science begins.
This is the kind of psychedelic research worth paying attention to. 🍄🧠
In a 2026 rat study, psilocybin after repetitive mild head injury was associated with reduced brain swelling, improved vascular function and connectivity, lower phosphorylated tau buildup, and increased BDNF-related signaling. (Nature)
That does not mean psilocybin has been proven to repair concussions in humans.
But the possibility that a compound famous for altering consciousness could also influence the biology of brain recovery?
That’s a question worth investigating.
The mushroom story keeps getting bigger.
Now this is where things get interesting. 🍄🧬
Psilocybin is usually discussed for what it does to the mind — but researchers are now exploring whether its effects may reach all the way down to cellular aging.
Early findings are fascinating, but this is nowhere near “magic mushrooms make you live longer.”
Still… the mushroom keeps getting more interesting.